Biologicals

Plant vaccines

Vaccines are effective means of reducing the disease burden of infectious diseases in developing countries. To ensure the widest availability of these vaccines in poor countries, approaches are needed with lower production costs and less need of medical personnel to administer the vaccines. A promising avenue is the development of plant-derived vaccines, which can be administered orally or to other mucosal surfaces. Plants are able to produce different classes of proteins of pharmaceutical significance at a high yield, leading to potentially inexpensive products. Oral administration is important as it diminishes the need for needles and syringes which require highly trained immunization staff.


RELATED LINKS

NEW PUBLICATIONS

TRS 1004 - WHO Expert Committee on Biological Standardization, Sixty-seventh report

UPCOMING EVENTS


  • WHO Working Group meeting on Respiratory Syncytial Virus (RSV) Vaccine Standardization, WHO headquarters, Geneva, Switzerland, 13-15 September 2017
  • WHO Second Working Group Meeting on Developing WHO Guidelines on safe production of polio vaccines, WHO HQ Salle D, 19-20 September 2017
  • WHO Workshop on Implementation of Good Manufacturing Practices for Biological Products, Bangkok, Thailand 15-17 November 2017
  • WHO Implementation Workshop on the Quality, Safety and Efficacy of Typhoid Conjugate Vaccines, Osong, Chungju-si, The Republic of Korea, 21-13 November 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971